Скачать с ютуб Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer в хорошем качестве

Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer

ASX: CU6 - Clarity Pharmaceuticals Executive Chair Alan Taylor on 3AW, 2GB, 4BC & 6PR on Bulls N' Bears Report Listen to ASX-listed Clarity Pharmaceuticals Executive Chair Alan Taylor talk to Matt Birney on radio - 3AW Melbourne, 2GB Sydney, 4BC Brisbane & 6PR Perth - on the Bulls N’ Bears Report about Clarity’s amazing clinical trial results that saw a complete response in one patient and lots with a 90 per cent plus reduction in signs of prostate cancer using “copper” based radiopharmaceuticals. Radiopharmaceuticals are a class of drugs with slightly radioactive isotopes that target and then either highlight or treat cancerous cells in the body. Clarity is developing its own version of radiopharmaceuticals known as targeted copper theranostics that use copper isotopes and a cage like biological structure that prevents that copper from leaking into the body while targeting cancerous tumours. The company is knee deep in a number of trials right now for prostrate cancer that are showing some seriously positive results. ----------------------- For more public company news, views and CEO interviews visit Bulls N' Bears website https://bullsnbears.com.au/ SOCIAL MEDIA   / bullsnbearswa     / bullsnbearswa     / bulls-n-bears-wa     / bullsnbearswa   https://www.bullsnbears.com.au/subscr... ----------------------- Medtech, Radiopharmaceuticals